Blog

Latest news about encapsia

DIA 2019 - There's nothing quite like Encapsia

Written by Jon Carter, Product Manager
01 Aug 2019

What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both Encapsia and our industry.

Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like Encapsia. It is not only built for today’s trials, but also for tomorrow’s. One of the themes of the week was the exciting area of artificial intelligence. Encapsia leads the market with analytics capabilities that are already proven to support AI, by analyzing and populating data from CT scans directly into the CRF.

Themes from DIA in previous years, in my opinion, have never fully reached fruition. Have we completely implemented risk based monitoring? There has been some great work in the area, but EDC systems are typically not flexible enough to dynamically adjust SDV down to the datapoint level. Encapsia has no hard-wired SDV mode, but instead has fully configurable review modes that allow you to dynamically set and adjust what requires SDV or any other type of review!

Overall, I am hugely encouraged by what we have seen at DIA 2019. Firstly, the industry is heading in the right direction, and secondly, Encapsia is made for that direction. There really isn’t anything quite like Encapsia for the future of clinical trials.


Last 3 posts

We are excited to announce that Cmed has today joined the AIXIAL Group and ALTEN Group. ALTEN is a world leader in Engineering and Technology consulting with 37,000 engineers and scientists located in more than 30 countries throughout the world. It serves customers in a range of industries and has a depth and breadth of experience and expertise across life sciences, software development and artificial intelligence. AIXIAL Group, an ALTEN company, is a CRO renowned for its flexible and functional resourcing.
At encapsia, we are pleased to be working with a like-minded partner in endpoint. With both organizations focused on simplifying the user experience and management of complex trials through technology, it was a natural step to integrate our two state-of-the-art technology systems to drive innovation and generate significant efficiencies in the clinical trial space. With encapsia, site users no longer need to use a separate IRT system – they do all their work in encapsia.
Each year we eagerly await the kick-off to the conference season with Arena’s Outsourcing in Clinical Trials (OCT) West Coast event. The conference brings together biotech and pharmaceutical clinical operations, outsourcing and procurement management, while showcasing innovations and technological advancements in the clinical trial space. This year was no exception and although the event was virtual, OCT West Coast managed to gather over 800 clinical trial professionals, looking to meet their peers and share insights into how we can conduct clinical trials of the future.